{"id":"https://openalex.org/W2933080993","doi":"https://doi.org/10.1186/s40425-019-0545-9","title":"Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity","display_name":"Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity","publication_year":2019,"publication_date":"2019-03-12","ids":{"openalex":"https://openalex.org/W2933080993","doi":"https://doi.org/10.1186/s40425-019-0545-9","mag":"2933080993","pmid":"https://pubmed.ncbi.nlm.nih.gov/30871609","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6419472"},"language":"en","primary_location":{"id":"doi:10.1186/s40425-019-0545-9","doi":"https://doi.org/10.1186/s40425-019-0545-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0545-9","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/67.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/7/1/67.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088400718","display_name":"Abhishek S. Kashyap","orcid":"https://orcid.org/0000-0003-2856-373X","observed_orcids":["https://orcid.org/0000-0003-2856-373X"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Abhishek S. Kashyap","raw_affiliation_strings":["Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland","Cancer Immunology, Department of Biomedicine","University Hospital Basel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Cancer Immunology, Department of Biomedicine","institution_ids":[]},{"raw_affiliation_string":"University Hospital Basel","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038740445","display_name":"Tamara Thelemann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tamara Thelemann","raw_affiliation_strings":["Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","Secarna Pharmaceuticals GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","institution_ids":[]},{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001552182","display_name":"Richard Klar","orcid":"https://orcid.org/0000-0001-6625-794X","observed_orcids":["https://orcid.org/0000-0001-6625-794X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Klar","raw_affiliation_strings":["Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","Secarna Pharmaceuticals GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","institution_ids":[]},{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066602305","display_name":"Sandra M. Kallert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sandra M. Kallert","raw_affiliation_strings":["Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland","Present address: Novartis Institute of Biomedical Research, 4002, Basel, Switzerland","Cancer Immunology, Department of Biomedicine","Present address: Novartis Institute of Biomedical Research","University Hospital Basel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Present address: Novartis Institute of Biomedical Research, 4002, Basel, Switzerland","institution_ids":["https://openalex.org/I4400600974"]},{"raw_affiliation_string":"Cancer Immunology, Department of Biomedicine","institution_ids":[]},{"raw_affiliation_string":"Present address: Novartis Institute of Biomedical Research","institution_ids":[]},{"raw_affiliation_string":"University Hospital Basel","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089607652","display_name":"Julia Festag","orcid":"https://orcid.org/0000-0001-6159-8286","observed_orcids":["https://orcid.org/0000-0001-6159-8286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia Festag","raw_affiliation_strings":["Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","Secarna Pharmaceuticals GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","institution_ids":[]},{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091717205","display_name":"M\u00e9lanie Buchi","orcid":"https://orcid.org/0000-0001-9958-9748","observed_orcids":["https://orcid.org/0000-0001-9958-9748"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Melanie Buchi","raw_affiliation_strings":["Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland","Cancer Immunology, Department of Biomedicine","University Hospital Basel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Cancer Immunology, Department of Biomedicine","institution_ids":[]},{"raw_affiliation_string":"University Hospital Basel","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056613055","display_name":"Lisa Hinterwimmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Hinterwimmer","raw_affiliation_strings":["Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","Secarna Pharmaceuticals GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","institution_ids":[]},{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003527997","display_name":"Monika Schell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monika Schell","raw_affiliation_strings":["Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","Secarna Pharmaceuticals GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","institution_ids":[]},{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013505557","display_name":"Sven Michel","orcid":"https://orcid.org/0000-0003-3604-3187","observed_orcids":["https://orcid.org/0000-0003-3604-3187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sven Michel","raw_affiliation_strings":["Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","Secarna Pharmaceuticals GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany","institution_ids":[]},{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044606591","display_name":"Frank Jaschinski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Frank Jaschinski","raw_affiliation_strings":["Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany. frank.jaschinski@secarna.com","Secarna Pharmaceuticals GmbH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH, Planegg/Martinsried, Germany. frank.jaschinski@secarna.com","institution_ids":[]},{"raw_affiliation_string":"Secarna Pharmaceuticals GmbH","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068350308","display_name":"Alfred Zippelius","orcid":"https://orcid.org/0000-0003-1933-8178","observed_orcids":["https://orcid.org/0000-0003-1933-8178"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Alfred Zippelius","raw_affiliation_strings":["Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland. alfred.zippelius@usb.ch","Medical Oncology, University Hospital Basel, Basel, Switzerland. alfred.zippelius@usb.ch","Cancer Immunology, Department of Biomedicine","Medical Oncology","University Hospital Basel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland. alfred.zippelius@usb.ch","institution_ids":["https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Medical Oncology, University Hospital Basel, Basel, Switzerland. alfred.zippelius@usb.ch","institution_ids":["https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Cancer Immunology, Department of Biomedicine","institution_ids":[]},{"raw_affiliation_string":"Medical Oncology","institution_ids":[]},{"raw_affiliation_string":"University Hospital Basel","institution_ids":["https://openalex.org/I2802542264"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5044606591","https://openalex.org/A5068350308"],"corresponding_institution_ids":["https://openalex.org/I2802542264"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":5.2976,"has_fulltext":true,"cited_by_count":60,"citation_normalized_percentile":{"value":0.97763864,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"7","issue":"1","first_page":"67","last_page":"67"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd39","display_name":"CD39","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9890000224113464},{"id":"https://openalex.org/keywords/locked-nucleic-acid","display_name":"locked nucleic acid","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cd73","display_name":"CD73","score":0.6830000281333923},{"id":"https://openalex.org/keywords/ectonucleotidases","display_name":"ectonucleotidases","score":0.8830000162124634},{"id":"https://openalex.org/keywords/extracellular-atp","display_name":"extracellular ATP","score":0.7400000095367432},{"id":"https://openalex.org/keywords/adenosine","display_name":"adenosine","score":0.9549999833106995},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.6320000290870667},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8700000047683716},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.9549999833106995},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.7793331146240234},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6717877388000488},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.5586609244346619},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5219849348068237},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.49735501408576965},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4559628665447235},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4427063763141632},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.43838411569595337},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.42082178592681885},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39974045753479004},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35985612869262695},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3321060538291931},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2936781942844391},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23095247149467468},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000255","descriptor_name":"Adenosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001081","descriptor_name":"Apyrase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007109","descriptor_name":"Immunity","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020868","descriptor_name":"Gene Silencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1186/s40425-019-0545-9","doi":"https://doi.org/10.1186/s40425-019-0545-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0545-9","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/67.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5415979","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6419472","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:30871609","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30871609","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6419472","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6419472/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:270e5351314041b4b9b45ed11b5860ce","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/270e5351314041b4b9b45ed11b5860ce","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)","raw_type":"article"},{"id":"mag:3207523598","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902264263212470","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1186/s40425-019-0545-9","doi":"https://doi.org/10.1186/s40425-019-0545-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0545-9","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/67.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2688561103","display_name":null,"funder_award_id":"KFS-3394-02-2014","funder_id":"https://openalex.org/F4320322583","funder_display_name":"Krebsliga Schweiz"},{"id":"https://openalex.org/G4078580680","display_name":"KMU-innovativ-19: DISTAT - Durchbrechen des immunsuppressiven Schutzwalls des Tumors durch Antisense-Oligonucleotid-Therapie","funder_award_id":"031B0459","funder_id":"https://openalex.org/F4320321114","funder_display_name":"Bundesministerium f\u00fcr Bildung und Forschung"}],"funders":[{"id":"https://openalex.org/F4320321114","display_name":"Bundesministerium f\u00fcr Bildung und Forschung","ror":"https://ror.org/04pz7b180"},{"id":"https://openalex.org/F4320322583","display_name":"Krebsliga Schweiz","ror":"https://ror.org/01pd7my79"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2933080993.pdf","grobid_xml":"https://content.openalex.org/works/W2933080993.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W636053789","https://openalex.org/W1969645166","https://openalex.org/W1974409640","https://openalex.org/W1977187462","https://openalex.org/W1980031208","https://openalex.org/W1983736296","https://openalex.org/W2042578211","https://openalex.org/W2049491375","https://openalex.org/W2053763669","https://openalex.org/W2086556660","https://openalex.org/W2088358411","https://openalex.org/W2097074641","https://openalex.org/W2097478351","https://openalex.org/W2105459360","https://openalex.org/W2106190040","https://openalex.org/W2111585885","https://openalex.org/W2112601576","https://openalex.org/W2131878959","https://openalex.org/W2142263069","https://openalex.org/W2149568090","https://openalex.org/W2159945718","https://openalex.org/W2170856427","https://openalex.org/W2171309772","https://openalex.org/W2171776498","https://openalex.org/W2251447490","https://openalex.org/W2344237909","https://openalex.org/W2463925486","https://openalex.org/W2561926137","https://openalex.org/W2566472201","https://openalex.org/W2591655768","https://openalex.org/W2605835842","https://openalex.org/W2612193865","https://openalex.org/W2765354611","https://openalex.org/W2766745368","https://openalex.org/W2807534769","https://openalex.org/W2809650769","https://openalex.org/W3146110766"],"related_works":["https://openalex.org/W2886359466","https://openalex.org/W2954130545","https://openalex.org/W6921136431","https://openalex.org/W6977545327","https://openalex.org/W6958788651","https://openalex.org/W6939848866","https://openalex.org/W6977294045","https://openalex.org/W6958474895","https://openalex.org/W3091241184","https://openalex.org/W2094049502"],"abstract_inverted_index":{"Background":[0],"Cancer":[1],"cells":[2,47,255,280],"are":[3,19],"known":[4],"to":[5,8,28,33,76,246,281,327],"develop":[6],"mechanisms":[7],"circumvent":[9],"effective":[10,77],"anti-tumor":[11,78,173],"immunity.":[12,79],"The":[13,132,163],"two":[14],"ectonucleotidases":[15],"CD39":[16,35,96,135,197,226,269,293,300,317],"and":[17,52,60,66,117,126,151,176,199,204,209,257],"CD73":[18],"promising":[20,322],"drug":[21],"targets,":[22],"as":[23,43,45],"they":[24],"act":[25],"in":[26,56,71,122,127,147,157,164,182,201,210,252,268,283,292,306,309],"concert":[27],"convert":[29],"extracellular":[30,64,161,217],"immune-stimulating":[31],"ATP":[32,65,146,218],"adenosine.":[34],"is":[36],"expressed":[37],"by":[38,142,222,228,318],"different":[39,49,202],"immune":[40,58,174,329],"cell":[41,124,149,155,207,236],"populations":[42],"well":[44],"cancer":[46,123,206],"of":[48,113,134,145,153,160,167,196,216,239,249,262,277,316],"tumor":[50,55,73,148,178,185,307],"types":[51],"supports":[53],"the":[54,72,158,275],"escaping":[57],"recognition":[59],"destruction.":[61],"Thus,":[62],"increasing":[63],"simultaneously":[67],"reducing":[68],"adenosine":[69],"concentrations":[70],"can":[74],"lead":[75],"Methods":[80],"We":[81],"designed":[82],"locked":[83],"nucleic":[84],"acid":[85],"(LNA)-modified":[86],"antisense":[87],"oligonucleotides":[88],"(ASOs)":[89],"with":[90,232,242,311],"specificity":[91],"for":[92,107],"human":[93,129,205,212],"or":[94,104],"mouse":[95,184],"that":[97],"do":[98],"not":[99],"need":[100],"a":[101,273,321],"transfection":[102],"reagent":[103],"delivery":[105],"system":[106],"efficient":[108],"target":[109,171],"knockdown.":[110],"Knockdown":[111],"efficacy":[112],"ASOs":[114,169,193,229,244,319],"on":[115,137,170,177],"mRNA":[116,198],"protein":[118,200],"level":[119],"was":[120,140,219,230,265,285,290],"investigated":[121],"lines":[125,208],"primary":[128,211],"T":[130,154,213,235,254,279,297],"cells.":[131,214,298],"effect":[133],"knockdown":[136,227],"ATP-degrading":[138],"activity":[139],"evaluated":[141],"measuring":[143],"levels":[144],"supernatants":[150],"analysis":[152],"proliferation":[156],"presence":[159],"ATP.":[162],"vivo":[165],"effects":[166],"CD39-specific":[168,192,223,243],"expression,":[172],"responses":[175,330],"growth":[179,308],"were":[180],"analyzed":[181],"syngeneic":[183],"models":[186],"using":[187],"multi-color":[188],"flow":[189],"cytometry.":[190],"Results":[191],"suppressed":[194],"expression":[195,251,289],"murine":[203],"Degradation":[215],"strongly":[220],"reduced":[221,267],"ASOs.":[224],"Strikingly,":[225],"associated":[231],"improved":[233],"CD8+":[234,278,296],"proliferation.":[237],"Treatment":[238],"tumor-bearing":[240],"mice":[241],"led":[245],"dose-dependent":[247],"reduction":[248,305],"CD39-protein":[250],"regulatory":[253],"(Tregs)":[256],"tumor-associated":[258],"macrophages.":[259],"Moreover,":[260],"frequency":[261],"intratumoral":[263,295],"Tregs":[264,282],"substantially":[266],"ASO-treated":[270,294],"mice.":[271],"As":[272],"consequence,":[274],"ratio":[276],"tumors":[284],"improved,":[286],"while":[287],"PD-1":[288],"induced":[291],"Consequently,":[299],"ASO":[301],"treatment":[302],"demonstrated":[303],"potent":[304],"combination":[310],"anti-PD-1":[312],"treatment.":[313],"Conclusion":[314],"Targeting":[315],"represents":[320],"state-of-the":[323],"art":[324],"therapeutic":[325],"approach":[326],"improve":[328],"against":[331],"tumors.":[332]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-04-11T00:00:00"}